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Abstract
Background: Although several studies have investigated whether CCL3L1 copy number variation (CNV) influences the risk
of HIV-1 infection, there are still no clear conclusions. Therefore, we performed a meta-analysis using two models to
generate a more robust estimate of the association between CCL3L1 CNV and susceptibility to HIV-1 infection.
Methods: We divided the cases and controls into two parts as individuals with CCL3L1 gene copy number (GCN) above the
population specific median copy number (PMN) and individuals with CCL3L1 GCN below PMN, respectively. Odds ratios
(ORs) with 95% confidence intervals (95% CIs) were given for the main analysis. We also conducted stratified analyses by
ethnicity, age group and sample size. Relevant literatures were searched through PubMed and ISI Web of Knowledge up to
March 2010.
Results: In total, 9 studies with 2434 cases and 4029 controls were included. ORs for the main analysis were 1.35 (95% CI,
1.02–1.78, model: GCN # PMN Vs. GCN . PMN) and 1.70 (95% CI, 1.30–2.23, model: GCN , PMN Vs. GCN $ PMN),
respectively. Either in stratified analysis, statistically significant results can be detected in some subgroups.
Conclusions: Our analyses indicate that CCL3L1 CNV is associated with susceptibility to HIV-1 infection. A lower copy
number is associated with an increased risk of HIV-1 infection, while a higher copy number is associated with reduced risk
for acquiring HIV-1.
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Introduction
Before 2009 acquired immunodeficiency syndrome (AIDS) has
took over 25 million people’s life, which have exceeded the death
toll of the First World War. What is worse, nearly 33 million
people suffered from HIV-1 infection [1]. It has been generally
accepted that genetic variants among individuals can regulate
HIV-1 cell entry, immune response and other factors that
influence the susceptibility to HIV-1 infection, disease progressing
and curative effects [2,3]. Recently, CCL3L1 (human CC
chemokine ligand 3-like 1) is recognized as one of the important
genetic factors for HIV-1 infection.
CCL3L1, also known as macrophage-inflammatory protein
1a(MIP-1a), locates on chromosome 17q11.2 with clusters of
cytokine genes. It can bind to several chemokine receptors
including CCR5, which is one of the most important co-receptors
for HIV-1 [4]. Binding of CCL3L1 to CCR5 may psychically
block HIV-1 entry into cells by inhabiting the requisite co-receptor
and suppress HIV viral replication in vitro [5]. Thus genetic
variations among individuals that regulate the expression of
CCL3L1 may influence susceptibility to HIV-1 infection.
CCL3L1 is highly variable in its copy number owing to having a
hot spot for segmental duplications in the human genome [6].
Most individuals have 1 to 6 copies per diploid genome, while few
individuals have 0 or more than 6 copies. Africans have larger
copy number of CCL3L1 than non-Africans [4].
Recently, several studies reported that CCL3L1 CNV is tightly
linked to HIV-1 susceptibility and processing a lower copy number
of CCL3L1 in the geographic ancestral population is associated
with increased risk of HIV-1 infection [7–12], whereas other
studies didn’t suggest this result [13–16]. Hence, we performed this
meta-analysis of eligible studies to explore a more robust estimate
of the association between CCL3L1 CNV and susceptibility to
HIV-1 infection.
Materials and Methods
Literature research
Literatures were screened through PubMed and ISI Web of
Knowledge up to March 2010, using the key words HIV-1,
susceptibility, CCL3L1, MIP-1a in various combinations. Titles
and/or abstracts were screened to estimate relevance of investi-
gations. Full texts of primary selected literatures were downloaded
for further study. Their references were hand-searched for
potential related investigations. Articles were restricted to English
language.
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The included investigations must accord with the following
criteria: (1) Case-control studies reporting the association of
CCL3L1 CNV and HIV-1 susceptibility; (2) Containing data of
distribution of CCL3L1 GCN among the cohorts; (3) Published
with English language. Major exclusion criteria as: (1) No sufficient
data of CCL3L1 GCN distribution among the cohorts; (2)
Reviews; (3) Duplication of previous studies.
Data extraction and statistical analysis
One author (Liu) searched for eligible investigations according
to the inclusion and exclusion criteria listed above. Study
characteristics including authors, countries, year of publication,
ethnicity, sample size of cohorts, distribution of CCL3L1 GCN
among the cohorts were extracted by 2 authors (Liu and Yao)
independently.
Crude ORs with 95% CIs were calculated to access the
association of CCL3L1 CNV and HIV-1 susceptibility. Two
genetic models were applied to analyse the distribution of
CCL3L1 GCN among the cohorts. In the GCN # PMN Vs.
GCN . PMN model, cases and controls were divided into two
parts as subjects with CCL3L1 GCN # PMN and subjects with
CCL3L1 GCN. PMN, respectively. And in the GCN , PMN
Vs. GCN $ PMN model, cases and controls were divided into two
parts as subjects with CCL3L1 GCN , PMN and subjects with
CCL3L1 GCN $ PMN, respectively. Stratified analyses were
performed by ethnicity, age group and sample size. Heterogeneity
across studies was assessed with chi-square-based Q-test [17] and
was considered significant if p,0.10, then the data were combined
basing on the random-effects (Dersimonian and Laird) model [18];
otherwise the fixed-effects (Mantel and Haenszel) model was
applied [19]. Publication bias was evaluated by Egger’s and Begg’s
tests with visual inspection of funnel plots and was considered
significant if p,0.05 [20,21]. One-way sensitivity analyses were
performed to examine the influence of individual studies on meta-
analysis’s results [22]. STATA version 10.0 (Stata Corporation,
College station, TX) was used for all analyses.
Results
Figure 1 indicates the selection process of literatures. We have
46 records searched through PubMed and ISI Web of Knowledge.
Figure 1. Selection process for study inclusion in the meta-analysis of CCL3L1 CNV and HIV-1 susceptibility.
doi:10.1371/journal.pone.0015778.g001
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ed from the remaining 21 articles for further analysis [6–17,23–
32]. Among them 5 reviews were excluded [6,24,28,30,32], 1
study was excluded for its study object wasn’t human being [26], 4
studies were excluded due to improper study direction (not aimed
at the association of CCL3L1 CNV and HIV-1 susceptibility)
[25,27,29,31]. During the extraction of data, 2 studies were
excluded due to insufficient data of CCL3L1 GCN distribution
among the cohorts [13,17].
Nine studies, involving 2434 HIV-1 infected patients and 4029
HIV-1 uninfected healthy donors, were included in this meta-
analysis. Study sample size ranged from 120 to 3173 subjects. Study
characteristics of the 9 eligible studies are summarized in Table S1.
There’re 5 studies involving subjects of African descendents
Figure 2. By using the GCN#PMN Vs. GCN.PMN model, (a) forest plot of overall analysis; (b) funnel plot to detect publication bias
in overall analysis. Data of studies involving mixed race was set apart according to different ethnicity. AA, African American; EA, European
American; HA, Hispanic American; OA, Other American except African American.
doi:10.1371/journal.pone.0015778.g002
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dents [9,10,12,14,16]. Four studies reported the effect of CCL3L1
CNV on HIV-1 susceptibility in mother-to-child transmission [7–
10], 6 studies were about adults [10–12,14–16].
In GCN # PMN Vs. GCN . PMN model, the pooled OR was
1.35 (95% CI, 1.02–1.78, P=0.000) (Figure 2a). Evaluation of
publication bias by funnel plot (Figure 2b), Begg’s test (P=0.855)
or Egger’s test (P=0.984) didn’t reveal significant results.
In GCN , PMN Vs. GCN $ PMN model, the pooled OR was
1.70 (95% CI, 1.30–2.23, P=0.000) (Figure 3a). No asymmetry is
observed in the funnel plot (Figure 3b), and neither Begg’s test
(P=0.373) nor Egger’s test (P=0.324) suggested publication bias.
Also, we performed stratified analyses by ethnicity, sample size
and age group to explore potential sources of heterogeneity and
detailed relationship between CCL3L1 CNV and susceptibility to
HIV-1 infection. The results were summarized in Table 1. Most of
Figure 3. By using the GCN,PMN Vs. CCL3L1 GCN$PMN model, (a) forest plot of overall analysis; (b) funnel plot to detect
publication bias in overall analysis. Data of studies involving mixed race was set apart according to different ethnicity.
doi:10.1371/journal.pone.0015778.g003
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that CCL3L1 CNV have distinct impact on susceptibility to HIV-
1 infection and a lower copy number of CCL3L1 in specific
population is associated with higher risk of HIV-1 infection.
Besides, results from subgroups stratified by age suggests hat
CCL3L1 may play different roles on the resistance to HIV-1
infection between infants and adults [10]. Since there was only one
study performed in Japanese, Indians and Argentineans respec-
tively, further studies on Asians and South Americans were
needed. The funnel plots of stratified analyses didn’t show
asymmetry (figure not shown), but the results of Egger’s test
suggested that publication bias was evident in sub-infants studies of
the GCN,PMN Vs. GCN$PMN model (P=0.027).
Sensitive analysis was conducted by deleting one study at a time
to examine the influence of individual data-set to the pooled ORs.
All of the corresponding pooled ORs were not materially altered
(Figure S1, S2).
Discussion
Meta-analysis offers a powerful method to synthesize informa-
tion of independent studies with similar target [33]. Considering a
number of studies investigating CCL3L1 CNV and HIV-1
susceptibility have generated conflicting results, we performed this
meta-analysis involving 9 eligible studies with 2434 cases and 4029
controls. The results suggested that CCL3L1 CNV is tightly linked
to HIV-1 susceptibility. Individuals with lower copy number of
CCL3L1 in the geographic ancestral population would be more
susceptible to HIV-1 infection. The CCL3L-CCL4L region shows
extensive architectural complexity, with smaller CNVs embedded
within larger ones and with interindividual variation in break-
points. Accounting for this genomic complexity is crucial for full
interpretation of association studies, because the combinatorial
content of CCL3L and CCL4L GCNs influences HIV/AIDS
susceptibility. Methodological and epidemiological confounders
and failure to account for the genomic complexity of the CCL3L-
CCL4L locus underlie the lack of associations reported by several
studies [34].
It is generally accepted that variations of gene copy number is a
genetic determinant of phenotypic variation [6]. Since CCL3L1
encodes the natural ligand of CCR5 and increasing copy number of
CCL3L1down-regulatestheexpressionofCCR5 onthe cellsurface
[10], the HIV-1 entry-dependent effect of CCL3L1 on CCR5 used
to be accepted as the major mechanism that inhibiting HIV-1
infection. Recent studies suggested that genotypes of CCL3L1-
CCR5 influence cell-mediated immunity of individuals [35].
Individuals with higher copy number of CCL3L1 have greater
CD4
+ and CD8
+ T cell response to HIV-1 gag protein [6,29].
These findings indicated that both viral entry dependent effect and
independent effect might explain the result of this meta-analysis.
Although the mechanism of CCL3L1 inhibiting HIV-1
infection has not been fully explored, outcomes of this meta-
analysis confirmed that CCL3L1 CNV have distinct impact on
HIV-1 susceptibility and a lower copy number of CCL3L1 in
specific population is associated with higher risk of HIV-1
infection. Several factors might underlie the lack of observed
association between CCL3L1 CNV and HIV-1 susceptibility.
First, relatively small sample size would lead to results with too
limited statistical power to detect possible relationship between
genetic polymorphism and disease risk in genetic association
studies [36]. Generally, large sample size is required for genetic
association studies of single gene and disease susceptibility
depending on the prevalence of the implicated polymorphism,
since susceptibility of specific disease is always determined by
numbers of genes [37]. Especially for people with relatively lower
copy number of CCL3L1 like Caucasians, insufficient sample size
would have generated a fluctuated risk estimate [38]. Second,
selection of cases might have significant influence on the results.
Infection with HIV-1 can exert a negative selective pressure on
individuals with lower copy number of CCL3L1. Over time, the
prevalence of cases with CCL3L1 copy number equal or greater
than specific population median will increase because subjects with
lower copy number of CCL3L1 progressed to AIDS or death
more rapidly [10]. Thus, if selected cases weren’t at an early stage
of infection, similar distribution of CCL3L1 copy number would
probably be observed in HIV-1 infected and uninfected subjects.
Fourth, the susceptibility to HIV-1 infection is affected by a
combination of genes besides CCL3L1. Nevertheless, few studies
had dissected the combinatorial genomic complexity posed by
varying proportions of distinct CCL3L and CCL4L genes among
individuals [40]. Finally, Although most of the studies adopted
similar real-time PCR method (Taqman assay) to measure the
copy number of CCL3L1 in samples, minor methodological
discrepancies of different studies as differences in DNA concen-
tration and differences in primer and probe dye chemistry might
have affected the results [39].
Some limitations of this meta-analysis should be acknowledged.
First, publication bias was evident in subgroup of infants/hospital-
based cases and hospital-based controls (P=0.027) and subgroup
of population-based cases and population-based controls (P=
0.014). The potential reason may be studies with advantage results
would be accepted and published more easily. Thus, more studies
are required for further analysis. Second, HIV-1 of R4 strain take
advantage of CXCR4 as co-receptor but not CCR5. Therefore,
virus entry-dependent effect of CCL3L1 won’t affect HIV-1
infection of R4 strain. Nevertheless the newly discovered virus
entry-independent effect might not be influenced despite HIV-1
virus type since most of the patients were infected by R5 strain. It
is unlikely that virus of X4 strain would significantly affect the
results. Third, in stratified analysis by ethnicity, the included
studies regarded mostly Europeans and Africans. Only 300
subjects of Japanese and 511 subjects of Indians were included
in published studies originated from Asia, which were too small to
have enough statistical power. Additional studies are warranted to
evaluate the association of CCL3L1 CNV and HIV-1 susceptibil-
Table 1. Results of meta-analysis for CCL3L1 CNV and HIV-1
susceptibility.
Study groups
GCN # PMN Vs.
GCN . PMN
GCN , PMN Vs.
GCN $ PMN
N
a OR (95% CI) P N
a OR (95% CI) P
Ethnicity
African 4 1.44 (0.87–2.40) 0.016 5 1.35 (0.83–2.20) 0.000
Caucasian 6 1.08 (0.76–1.53) 0.001 5 1.73 (1.09–2.75) 0.000
Japanese 1 2.92 (1.69–5.07) 2 1 3.50 (2.10–5.86) 2
Sample size
,500 subjects 8 1.35 (0.81–2.25) 0.000 8 1.58 (1.00–2.50) 0.000
.500 subjects 5 1.38 (1.00–1.92) 0.000 4 1.94 (1.48–2.55) 0.011
Age group
Infants 4 2.01 (1.58–2.56) 0.274 4 2.10 (1.68–2.63) 0.994
Adults 9 1.19 (0.86–1.65) 0.000 8 1.55 (1.05–2.28) 0.000
aNumber of comparisons.
doi:10.1371/journal.pone.0015778.t001
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estimates by currently quantitative PCR assays suffer from
relatively low precision and accuracy with increasing gene copy
number. In studies of Caucasians or other ethnicities that the
median copy number of CCL3L1 is 2 or less, the methodological
shortcomings should be a minor concern. But it might be more
troublesome in studies of Africans with higher copy number [38].
Newer method with higher precision and accuracy will be helpful
for a more exact estimate of the association between CCL3L1
CNV and HIV-1 susceptibility. Finally, controls of most studies
were derived from healthy individuals. For studies concerning
disease susceptibility, it’ll be more proper to take samples from
HIV-1-exposed seronegative (HES) individuals as controls.
Considered the difficulty of obtaining samples from HES
individuals, further studies of larger scale is required.
In conclusion, our meta-analysis involving 9 eligible studies with
a total of more than 6000 subjects indicated significant association
between CCL3L1 CNV and HIV-1 susceptibility. A lower copy
number of CCL3L1 in the geographic ancestral population is
associated with higher risk of HIV-1 infection. For further studies,
it seems to be crucial to define precisely the genomic structure,
taking into account the specific combination of the distinct genes
within a CNV region [40], and considering (1) mechanism of
CCL3L1 against HIV-1 infection; (2) discrepancies of methods on
measuring CCL3L1 gene copy number; (3) CCL3L1’s effect on
Asians; (4) HES individuals as controls.
Supporting Information
Figure S1 Sensitive test of the GCN#PMN Vs.
GCN.PMN model.
(TIF)
Figure S2 Sensitive test of the GCN,PMN Vs. CCL3L1
GCN$PMN model.
(TIF)
Table S1 Characteristics of studies included in the
meta-analysis.
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